Sign in

NCT03069924CompletedPhase 2

Gain-framed Messages and NRT for Lung Cancer Screening Patients

Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs

Source: ClinicalTrials.gov · Last updated 14 Jan 2025

Brief summary (registry, in English)

This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients, which will grow dramatically now that lung screening is an approved CMS benefit. In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs. unframed messaging), as well as evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be translational (in that it can be transferable from our controlled efficacy study to other lung screening programs).

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
367 (actual)
First submitted
28 Feb 2017
Start date
1 Jul 2017
Primary completion date
10 Nov 2023
Lead sponsor
Medical University of South Carolina
Diseases
Lung cancer
NCT number
NCT03069924

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 367
  • From 1 Jul 2017 to the primary completion date, 10 Nov 2023
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • current participation in another tobacco treatment program (e.g., using medication from a primary care doctor, Quitline, etc.)

Other illness

  • unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia,
  • known allergy to adhesives
  • being in the immediate (within 2 weeks) post myocardial infarction period
  • serious arrhythmias
  • unstable angina pectoris

Other

  • hemodynamically or electrically unstable.

Who the study is looking for

  • 50 years or older
  • at least a 20-pack year history of smoking
  • current smoker (defined as any smoking in the past 30 days)
  • willing to be randomized
  • English speaking

Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Medical University of South Carolina
Coordinator of this site? Confirm its status
CharlestonUnited StatesUnknown status
Yale Cancer Center
Coordinator of this site? Confirm its status
New HavenUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.